Intravenous 2-Hydroxypropyl-Β-Cyclodextrin (Trappsol® Cyclo™) Demonstrates Biological Activity and Impacts Cholesterol Metabolism in the Central Nervous System and Peripheral Tissues in Adult Subjects with Niemann-Pick Disease Type C1: Results of a Phase 1 Trial
Caroline A. Hastings(UCSF Benioff Children's Hospital), Sharon Hrynkow(Unknown)
Cited by 2
Related Papers
Recombinant Urate Oxidase for the Prophylaxis or Treatment of Hyperuricemia in Patients With Leukemia or Lymphoma
|Journal of Clinical Oncology|2001|367